Loading…
5 companies · GEL, thousands · columns ordered by revenue
Only 3 of 5 peers filed FY2024. Switch to FY2023 (5 of 5).
| Line item | Tvalis Klinika | Sameditsino Parazitolog… | Saprotezo Ortopediuli R… | Atlas Medical | Med-Diagnostika |
|---|---|---|---|---|---|
| Total Revenue | 1,260 | 1,242 | 873 | — | — |
| Total COGS | 0 | -568 | -314 | — | — |
| Gross Profit | 1,260 | 674 | 559 | — | — |
| Gross Margin | 100.0% | 54.3% | 64.1% | — | — |
| Total Operating Expenses | -1,119 | -479 | -478 | — | — |
| EBITDA | 141 | 195 | 82 | — | — |
| EBITDA Margin | 11.2% | 15.7% | 9.3% | — | — |
| Total D&A | -61 | -10 | -39 | — | — |
| EBIT / Operating Income | 81 | 185 | 42 | — | — |
| Total Interest Expense | -221 | -19 | -34 | — | — |
| Total Other Income | -1 | 53 | 39 | — | — |
| Profit Before Tax | -141 | 229 | 48 | — | — |
| Total Income Tax | 0 | -7 | 0 | — | — |
| Net Profit / (Loss) | -141 | 239 | 48 | — | — |
| Net Margin | -11.2% | 19.2% | 5.5% | — | — |
| Total Interest Income | — | 10 | — | — | — |
Not every picked company reports every selected year — FY2024: no filing for Med-Diagnostika and Atlas Medical. Those cells are left blank (no filing), not zero.
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Sameditsino Parazitolog… | Healthcare Services | 15.7% | 67th pct | 268 |
| Tvalis Klinika | Healthcare Services | 11.2% | 55th pct | 268 |
| Saprotezo Ortopediuli R… | Healthcare Services | 9.3% | 49th pct | 268 |
| Atlas Medical | Healthcare Services | — | no FY data | 268 |
| Med-Diagnostika | Healthcare Services | — | no FY data | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.